You are browsing the Hong Kong website, Regulated by Hong Kong SFC (CE number: BJA907). Investment is risky and you must be cautious when entering the market.
三連板揚帆新材(300637.SZ):苯硫酚可作為鹽酸阿比朵爾上游原料 已收到石四藥等生產商訂單
格隆匯 02-07 18:31

格隆匯2月7日丨揚帆新材(300637.SZ)連續三個交易日漲停,今日晚間發佈股票交易異常波動及風險提示公告稱,自新型冠狀病毒肺炎疫情發生以來,政府和社會高度重視。公司巰基化合物系列產品主要以中間體狀態應用於醫藥、農藥、染料等領域。其中苯硫酚下游可用於抗病毒藥品鹽酸阿比朵爾的生產,而鹽酸阿比朵爾被多省市列入新型冠狀病毒肺炎防控首批藥品儲備清單。

春節前後,公司收到了石家莊四藥有限公司、江蘇吳中醫藥集團等國內主要阿比朵爾生產商關於協調阿比朵爾原料供應的協調函或説明函後,公司馬上安排人員與客户溝通對接,並辦理產品運輸等手續,並於2月5日將第一批產品發往石家莊四藥有限公司,儘可能保障儲備藥品的供應。

根據2月4日晚上相關媒體的報道,李蘭娟團隊在武漢公佈阿比朵爾在10~30微摩爾濃度下,與藥物未處理的對照組比較,能有效抑制冠狀病毒達到60倍,並且顯著抑制病毒對細胞的病變效應。另外,李蘭娟本人也建議將阿比朵爾和達蘆那韋列入國家衞健委《新型冠狀病毒感染的肺炎診療方案(試行第六版)》。

但到目前為止,尚無充足的臨牀研究證據表明鹽酸阿比朵爾對“新型冠狀病毒”有療效,也未列入新型冠狀病毒感染的肺炎診療方案。

Follow us
Find us on Facebook, Twitter , Instagram, and YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!
Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.
uSMART
Wealth Growth Made Easy
Open Account